Moreover, PLX5622 treatment significantly reduced Tmem119 expression in brains after stroke, compared to naïve or normal diet administered brains (Fig. 3e, p < 0.05, compared to naïve and ND-stroke). This evidence concerns the gene TMEM119 and stroke disorder.